Analyst Consensus ?
ConsensusBuy29 ratings
Bullish1551.7%
Neutral1448.3%
Bearish00.0%
IDEX Corporation · IEX · FY2026 Q3 · Calendar Q4 2026
IDEX raises 2026 outlook as advantage-market demand stays strong
The quarter supports a constructive operating trajectory: management described record orders and strength in data centers, semiconductors, space and defense, while raising the full-year organic-growth outlook. The main test is whether HST momentum and data-center demand remain durable as weaker end markets and input-cost pressure persist.
Reported Before market openNYSEIndustrials
$17.19B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $2.24
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $934.4M
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+2.3%
Event window
SPY move
+0.3%
Same window
Abnormal move
+1.9%
Stock minus SPY
Volume
2.3×
Versus trailing sessions
Subsequent drift
0.0%
Up to 20 sessions
IEXSPY benchmark
Ask FN2 about IEX FY2026 Q3
Transcript, numbers and history already loaded
What drove IEX's +2.3% move after FY2026 Q3 earnings?What changed in IEX's guidance and outlook in FY2026 Q3?Give me the bull and bear case for IEX after FY2026 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Management reported a record order quarter and said Q3 performance exceeded guidance on sales, margins and EPS. The full-year 2026 organic-revenue-growth outlook increased to 6.5%-6.8% from the prior 5%-6% range; capex remains around $110 million, alongside continued repurchases and bolt-on M&A.
Guidance delta
Raised: full-year 2026 organic revenue growth to 6.5%-6.8% from 5%-6% previously. Management also said pricing is expected to contribute roughly 2% of 2026 top-line growth; the analysis does not provide a new full-year EPS or EBITDA target.
Key takeaways
- Orders grew 13% organically to nearly $1 billion, a record level for the quarter.
- Management highlighted data centers, semiconductors, space and defense, and municipal water as key demand areas.
- Integrated-platform tunability and recent acquisitions are being used to enter higher-growth applications.
- The capital plan keeps annual capex near $110 million and quarterly repurchases near $75 million.
- Pricing and productivity are helping offset inflation, while some chemicals, agriculture and energy businesses remain weak.
Management priorities
- Fund growth initiatives with approximately $110 million of annual capex.
- Expand the intelligent water platform and iDx analytics offering.
- Pursue complementary bolt-on acquisitions while maintaining disciplined capital allocation.
- Use platform tunability to enter aerospace, advanced optics and other high-growth applications.
Follow IEX with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$238.54Current
$205Low
$244.6Average
$280High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Oppenheimer | Outperform | Outperform | Maintain | Oct 21, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 14, 2026 |
| Mizuho | Outperform | Neutral | Upgrade | Aug 12, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | Aug 6, 2026 |
| Argus Research | Buy | Buy | Maintain | Aug 6, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 30, 2026 |
| Stifel | Buy | Buy | Maintain | Jul 30, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 30, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Mar 27, 2026 |
| Baird | Outperform | Outperform | Maintain | Oct 31, 2024 |
| Wells Fargo | Overweight | Overweight | Maintain | Apr 28, 2023 |
| Bernstein | Market Perform | Market Perform | Maintain | Apr 28, 2023 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jan 18, 2023 |
| Loop Capital | Hold | Hold | Maintain | Jul 19, 2022 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Mar 9, 2022 |
| Rosenblatt | Buy | Buy | Maintain | May 3, 2021 |
| Janney Montgomery Scott | Neutral | Buy | Downgrade | Apr 8, 2020 |
| Janney Capital | Neutral | Buy | Downgrade | Apr 8, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Jul 29, 2019 |
| Berenberg | Buy | Buy | Maintain | May 15, 2019 |
| UBS | Neutral | Neutral | Maintain | Jan 23, 2018 |
| KeyBanc | Equal Weight | Sector Weight | Maintain | May 23, 2016 |
| SunTrust Robinson Humphrey | Neutral | Neutral | Maintain | Nov 3, 2015 |
| Jefferies | Hold | Hold | Maintain | Jun 12, 2015 |
| Brean Capital | Buy | Hold | Upgrade | Jan 30, 2014 |
| Longbow Research | Neutral | Neutral | Maintain | Oct 1, 2013 |
| BB&T Capital | Hold | Hold | Maintain | Mar 15, 2013 |
| CL King | Neutral | Buy | Downgrade | Dec 12, 2012 |
| Barrington Research | Outperform | Outperform | Maintain | Jul 24, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $238.54. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Stifel Nicolaus | Analyst unavailable | $267 | $235.55 | +11.9% | Oct 19, 2026 |
| Oppenheimer | Analyst unavailable | $270 | $225.66 | +13.2% | Sep 9, 2026 |
| Vertical Research | Jeffrey Sprague | $250 | $223.74 | +4.8% | Sep 8, 2026 |
| Mizuho Securities | Brett Linzey | $280 | $237.31 | +17.4% | Aug 11, 2026 |
| D.A. Davidson | Analyst unavailable | $240 | $234.88 | +0.6% | Aug 6, 2026 |
| Oppenheimer | Analyst unavailable | $265 | $236.82 | +11.1% | Jul 30, 2026 |
| Stifel Nicolaus | Nathan Jones | $268 | $229.52 | +12.4% | Jul 30, 2026 |
| Stifel Nicolaus | Nathan Jones | $257 | $224.94 | +7.7% | Jul 20, 2026 |
| RBC Capital | Analyst unavailable | $261 | $227.6 | +9.4% | Jul 16, 2026 |
| Oppenheimer | Analyst unavailable | $250 | $207.59 | +4.8% | Jun 2, 2026 |
| Seaport Global | Walt Liptak | $250 | $215.78 | +4.8% | May 5, 2026 |
| RBC Capital | Analyst unavailable | $252 | $217.93 | +5.6% | Apr 30, 2026 |
| Stifel Nicolaus | Analyst unavailable | $250 | $217.68 | +4.8% | Apr 30, 2026 |
| Oppenheimer | Analyst unavailable | $242 | $217.34 | +1.5% | Apr 30, 2026 |
| Robert W. Baird | Analyst unavailable | $257 | $217.34 | +7.7% | Apr 30, 2026 |
| Stifel Nicolaus | Analyst unavailable | $241 | $205.12 | +1.0% | Apr 14, 2026 |
| BMO Capital | Analyst unavailable | $214 | $189.73 | -10.3% | Mar 26, 2026 |
| Seaport Global | Analyst unavailable | $240 | $212.26 | +0.6% | Feb 9, 2026 |
| Argus Research | Analyst unavailable | $240 | $212.94 | +0.6% | Feb 6, 2026 |
| RBC Capital | Analyst unavailable | $244 | $211.02 | +2.3% | Feb 5, 2026 |
| Oppenheimer | Bryan Blair | $230 | $209.86 | -3.6% | Feb 5, 2026 |
| Robert W. Baird | Michael Halloran | $247 | $212.25 | +3.5% | Feb 5, 2026 |
| Stifel Nicolaus | Analyst unavailable | $220 | $196.43 | -7.8% | Jan 23, 2026 |
| RBC Capital | Analyst unavailable | $211 | $194.99 | -11.5% | Jan 15, 2026 |
| RBC Capital | Analyst unavailable | $195 | $175.97 | -18.3% | Oct 30, 2025 |
| Stifel Nicolaus | Analyst unavailable | $191 | $167.51 | -19.9% | Oct 20, 2025 |
| Oppenheimer | Analyst unavailable | $210 | $167.05 | -12.0% | Oct 7, 2025 |
| D.A. Davidson | Analyst unavailable | $180 | $158.25 | -24.5% | Aug 4, 2025 |
| Mizuho Securities | Brett Linzey | $185 | $190.85 | -22.4% | May 16, 2025 |
| Robert W. Baird | Michael Halloran | $215 | $181.45 | -9.9% | May 2, 2025 |
| Mizuho Securities | Brett Linzey | $175 | $166.4 | -26.6% | Apr 22, 2025 |
| RBC Capital | Deane Dray | $248 | $218.64 | +4.0% | Oct 31, 2024 |
| D.A. Davidson | Matt Summerville | $210 | $194.12 | -12.0% | Aug 5, 2024 |
| Oppenheimer | Bryan Blair | $238 | $192.75 | -0.2% | Aug 5, 2024 |
| Robert W. Baird | Michael Halloran | $256 | $224.64 | +7.3% | Apr 25, 2024 |
| Stifel Nicolaus | Nathan Jones | $265 | $225.83 | +11.1% | Feb 8, 2024 |
| Stifel Nicolaus | Nathan Jones | $188 | $186.26 | -21.2% | Jul 18, 2022 |
| RBC Capital | Deane Dray | $238 | $188.06 | -0.2% | May 9, 2022 |
| Citigroup | Analyst unavailable | $235 | $191.15 | -1.5% | Apr 28, 2022 |
| Mizuho Securities | Analyst unavailable | $205 | $191.42 | -14.1% | Apr 28, 2022 |
| Bernstein | Brendan Luecke | $230 | $224.3 | -3.6% | Jan 10, 2022 |
| D.A. Davidson | Matt Summerville | $220 | $222.43 | -7.8% | Oct 28, 2021 |
| Morgan Stanley | Connor Lynagh | $250 | $225.91 | +4.8% | Apr 29, 2021 |
Track every rating change on IEX the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationIDEX Corporation is an international enterprise specializing in engineered solutions across diverse sectors. The company operates through three primary business units: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT division is responsible for the design, production, and distribution of a range of fluid-handling equipment, including positive displacement pumps, flow meters, and injectors, alongside offering flow monitoring and related services. Its applications span the food, chemical, general industrial, water management, agricultural, and energy industries. Under the HST umbrella, IDEX develops and supplies precision components and systems for health and scientific applications.…
Historical context
All IEX earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| LII Lennox International Inc. | FY2026 Q3 · Calendar Q4 2026 | — | -10.6% | Lennox cuts outlook as pricing and tariffs pressure margins |
| CHRW C.H. Robinson Worldwide, Inc. | FY2026 Q3 · Calendar Q4 2026 | — | -11.1% | C.H. Robinson: Lean AI, RXO and Margin Expansion |
| CR Crane Company | FY2026 Q3 · Calendar Q4 2026 | +12.6% | +2.9% | Crane posts record Q3 and raises full-year EPS guidance |
| VRT Vertiv Holdings Co | FY2026 Q3 · Calendar Q4 2026 | — | +16.5% | Vertiv raises 2026 outlook as AI infrastructure demand accelerates |
| CLH Clean Harbors, Inc. | FY2026 Q3 · Calendar Q4 2026 | — | +0.1% | Clean Harbors raises 2026 EBITDA outlook after record Q3 |
| FER Ferrovial N.V. | FY2026 Q3 · Calendar Q4 2026 | — | +7.3% | Ferrovial: Core infrastructure growth and new U.S. awards stand out |
Latest beats and misses
Who reports nextBeat on EPS
- EXEFY2026 Q3 · October 27, 2026+13.2% EPS-3.2% move
- CRFY2026 Q3 · October 27, 2026+12.6% EPS+2.9% move
- PPGFY2026 Q3 · October 27, 2026+6.1% EPS+4.4% move
- UMBFFY2026 Q3 · October 27, 2026+10.6% EPS-1.1% move
- UHSFY2026 Q3 · October 27, 2026+0.6% EPS-2.9% move
- ACGLNFY2026 Q3 · October 27, 2026+15.6% EPS-0.9% move
Get the IEX recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-10-28T16:05:32.482354+00:00
- FN2 earnings calendar · 2026-10-28T01:23:13.546025+00:00
- Polygon adjusted daily market bars · 2026-10-29T00:10:46.008659+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-29T00:10:46.005834+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-29. For educational purposes only; not investment advice.